Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Comment by FactFinder1994on Jan 27, 2021 11:17pm
82 Views
Post# 32406600

RE:Page 5 math

RE:Page 5 mathWell done - you either follow closely or catch on quick.  
I won't argue with your math, other than to say it may be on the conservative side.  
I would also add the Heart and Pancreas to your future list of Organ opportunities too.

There are a total of four North American Transplant Centers and in the MD&A (page 5) it indicates that SQI's research partner (UHN), is increasing the procurement, stabilization and transportation of organs etc.....Goes on to say that SQI's TORdx Lung Test will be leveraged within the EVLP market and directly to transplant hospitals.  The opportunity here keeps growing significantly.

A non financial positive I feel proud to share is that not only will there be significantly more transplants, but there will also be greater odds of success with each transplant.  When referring to lives, that in itslef is a big deal.      
 
Stay tuned, 

<< Previous
Bullboard Posts
Next >>